Organ Function Assays – Medical Devices Pipeline Assessment, 2019

2019-11-01
Price :
Published : Nov-2019
No. of Pages : 68

Organ Function Assays – Medical Devices Pipeline Assessment, 2019

Summary

GlobalData’s Medical Devices sector report, “Organ Function Assays – Medical Devices Pipeline Assessment, 2019” provides an overview of Organ Function Assays currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Organ Function Assays pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

– Extensive coverage of the Organ Function Assays under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Organ Function Assays and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Reasons to buy

The report enables you to –
– Formulate significant competitor information, analysis, and insights to improve R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of Organ Function Assays under development
– Develop market-entry and market expansion strategies
– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
Publisher : GlobalData
More Reports
Title Price Buy Now

Patient Engagement Solutions Market by Component (Hardware, Software, Services), Delivery Mode (On Premise, Cloud), End User (Provider, Payer), Applications (Home Health, Financial Health), Therapeutic Area – Analysis and Global Forecast to 2025

“The patient engagement solutions market is projected to grow at a CAGR of 10.1% due to the 5.2.1.1  Implementation of government regulations and initiatives to promote patient-centric care.” The global patient engagement solutions market is projected to reach USD 19.3 billion by 2025 from USD 11.9 billion in 2020, at a CAGR of 10.1% during the forecast period. The growth of this market is driven by the implementation of government regulations and initiatives to promote patient-centric care, increasing demand for patient engagement solutions, and the increasing utilization of mobile health apps. However, a lack of interoperability of PES and a dearth of skilled IT professionals in the healthcare industry are expected to restrain the growth of this market during the forecast period.......
$4950

Radiation Dose Management Market by Products & Services (Standalone Solutions, Integrated Solutions, Services), Modality (Computed Tomography, Nuclear Medicine), Application (Oncology, Cardiology, Orthopedic), End User (Hospitals) – Global Forecast to 2025

“Radiation dose management market is projected to grow at CAGR of 13.9% from 2020 to 2025” The global radiation dose management market is projected to reach USD 422.65 million by 2025 from USD 220.22 million in 2020, at a CAGR of 13.9% from 2020 to 2025. Growth in this market is driven by the increasing use of medical imaging modalities due to the rising incidence of chronic diseases, increasing concerns over radiation dose exposure, growth in the installed base of radiology equipment, and growing awareness on radiation dose management. On the other hand, the lack of standardized procedures and dose protocols for radiation dose management for healthcare organizations is a major market challenge. “Radiation dose management solutions segment to witness the highest growth during t......
$4950

Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer

Coronavirus Disease 2019 (COVID-19) Clinical and Commercial Analyzer Summary When faced with an outbreak of a pathogen with no known treatments, we are forced to rely on the pharmaceutical industry to develop interventions to curb these potential disasters. The COVID-19 Clinical and Commercial Analyzer is an interactive Excel-based tool that scores leading pipeline-stage vaccines and therapeutics on a range of clinical and commercial parameters based on available clinical data. The catalyst for the initial release of this analysis, dated August 10, 2020, includes all clinical data readouts and other market-altering events that have occurred since the outbreak's inception. With the constantly evolving COVID-19 outbreak, players need rapidly updated and detailed information on the potent......
$4995

United States In Vitro Diagnostics Market Outlook to 2025 – Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others

United States In Vitro Diagnostics Market Outlook to 2025 - Cardiac Disease, Clinical Chemistry, Hematological Disorders and Others Summary GlobalData's "United States In Vitro Diagnostics Market Outlook to 2025" is a comprehensive databook report, covering key market data on the United States In Vitro Diagnostics market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Disease, Clinical Chemistry, Hematological Disorders, Hormonal Disorders, Infectious Disease, IVD Analyzers and Reagents, Metabolic Disorder, Oncology and Women's Health. The United States In Vitro Diagnostics Market report provides key information and data on - - Annualized market revenues (USD), volume (units) and average prices (USD) data for each of t......
$5995

Graft Versus Host Disease (GvHD): Forecast in Asia-Pacific Markets to 2028

Graft Versus Host Disease (GvHD): Forecast in Asia-Pacific Markets to 2028 Summary Graft versus host disease (GvHD) is a morbid disease and accounts for the highest cause of non-relapse mortality following allogeneic hematopoietic stem cell transplant (HSCT). Mortality is caused by either extensive tissue damage or uncontrolled opportunistic infection due to the immunosuppressive properties of the current GvHD treatment. Drug-related toxicity issues also contribute significantly to morbidity and mortality in GvHD. The GvHD market is expected to undergo significant change and growth over the next 10 years across the five growth pharmaceutical markets (5GM; India, China, Australia, South Korea, and Japan) covered in this report. In this report, GlobalData analyses the current GvHD treatmen......
$8995

Coronavirus Disease 2019 (COVID-19) Impact on Immunology Trials – July 2020

Coronavirus Disease 2019 (COVID-19) Impact on Immunology Trials - July 2020 Summary Since the beginning of March 2020, clinical trial operations were most disrupted as a result of the COVID-19 pandemic. This report summarizes the impact on immunology patient, clinical trial logistics, and key opinion leader (KOL) insights on the long-term impact of the pandemic. Scope - Global overview of changes to clinical practice and clinical trial logistics in H1 2020 in 8MM (US, 5EU, Japan, Canada) - Summary of primary research with Immunology Key Opinion Leaders - Forward-looking perspective of potential long-term ramifications of COVID pandemic Reasons to Buy - Understand the impact of COVID-19 on immunology clinical trials - Obtain a snapshot of the regulatory guidance issued by the US FDA, ......
$595

Coronavirus Disease 2019 (COVID-19) – Pipeline and Clinical Trial Analysis – June 2020

Coronavirus Disease 2019 (COVID-19) - Pipeline and Clinical Trial Analysis - June 2020 Summary The biopharmaceutical industry has risen to meet the challenge posed by this novel virus: hundreds of companies across the globe have entered the race to develop a treatment and a preventive vaccine. While the industry has shown its mettle by immediately initiating research on agents for COVID-19, the progress of R&D in general has been adversely impacted, with delays in clinical trial timelines and regulatory decisions across disease areas. Over the coming months, as trial data readouts become available, frontrunners will emerge in both the therapeutic and preventive categories. Currently, the therapeutics space is dominated by candidates already approved for other disease indications; one of......
$2495

Coronavirus Disease 2019 (COVID-19) – Analysis of the Emerging Disease Landscape – June 2020

Coronavirus Disease 2019 (COVID-19) - Analysis of the Emerging Disease Landscape - June 2020 Summary The Epidemiology of COVID-19 is rapidly evolving and a number of companies have begun to invest in this space. The absence of proven therapeutic options and the lack of a vaccine to protect against infection has led to a race to develop effective interventions. A range of players - from pharma and biotech firms to academic institutions and government agencies - have thrown their hats in the ring. Scope - Global epidemiology metrics and trends - Snapshot of epidemiological trends to date in the top three most-affected countries - An overview of the pipeline for antivirals and vaccines - Summary of available efficacy data - An assessment of the clinical trials landscape by phase, sponsor ......
$2495

Contract Manufacturing Service Agreements – Rising Manufacturing Opportunities Driven by Pharmaceutical Pipeline Expansion

Contract Manufacturing Service Agreements - Rising Manufacturing Opportunities Driven by Pharmaceutical Pipeline Expansion Summary This report is a brand new publication covering contract service agreements, across a range of different services and manufacturing scales. The number of contract service agreements secured serves as a primary indicator of a CMO's performance. Contract Manufacturing Service Agreements is critical for establishing an understanding of the overall CMO industry, the range of services provided and the features of some of the largest CMOs participating in the industry. This report gives an important expert quantitative analysis on the contract manufacturing industry. Findings are based on the industry's most comprehensive databases of the CMO industry (GlobalData'......
$4995

COVID-19 Pipeline of Small and Mid-Cap Bio/Pharma Companies – Coronavirus Disease 2019 Sector Forecast

COVID-19 Pipeline of Small and Mid-Cap Bio/Pharma Companies - Coronavirus Disease 2019 Sector Forecast Summary The Coronavirus (COVID-19) company impact report analyses how the pandemic has impact Small and Mid Bio/Pharma Companies. Scope - This PowerPoint based report gives an important expert analysis on how the developement of vaccines and therapeutics for COVID-19 has been approached by Small and Mid Cap Bio/Pharma Companies. - Findings are based on the industry's most comprehensive platform the Pharma Intelligence Center, including Deals, News, Drugs, Sales, Clinical Trials database and recent analysis. Reasons to Buy - An overview of how Small and Mid Cap Bio/Pharma Companies have approached the developemnt of vaccines and therapeutics for the COVID-19 pandemic.......
$695
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy